JAK1 rs310241 and JAK3 rs3008 Genotypes May Increase Susceptibility to Psoriasis: A Case Control Study
Authors:
- 2 September 2020
- journal article
- research article
- Published by S. Karger AG in Skin Pharmacology and Physiology
- Vol. 33 (4) , 207-212
Abstract
Background: Janus kinases (JAKs) are a family of non-receptor protein tyrosine kinases that are expressed in a variety of tissues. Several JAK-controlled cytokine receptor pathways are incriminated in the initiation and progression of psoriasis. Genetic polymorphisms influencing JAK expression would be anticipated to have a great impact on disease activity. Objective: The aim of the study was to evaluate the association between JAK1 rs310241 and JAK3 rs3008 polymorphisms and the risk of developing psoriasis. Methods: Blood samples of 150 patients and 120 controls were screened for nucleotide polymorphisms in JAK1 rs310241 and JAK3 rs3008 genes by using polymerase chain reaction (PCR)-restriction fragment length polymorphism technique. Results: The GG genotype of the JAK1 rs310241 and JAK3 rs3008 genes was significantly associated with an increase in psoriasis risk (p = 0.000, OR = 7.7, 95% CI = 2.8–21.5; p = 0.003, OR = 3.3, 95% CI = 1.5–6.9, respectively). The G allele of both genes was also associated with psoriasis susceptibility (p = 0.000, OR = 2.0, 95% CI = 1.4–2.8; p = 0.002, OR = 1.7, 95% CI = 1.2–2.4, respectively). Conclusion: The results indicate a possible association between JAK1 rs310241 and JAK3 rs3008 gene polymorphisms and susceptibility to psoriasis. These findings validate the importance of these molecules in psoriasis and may enable the identification of the individuals most susceptible to the disease.Keywords
This publication has 30 references indexed in Scilit:
- A Restricted Role for TYK2 Catalytic Activity in Human Cytokine Responses Revealed by Novel TYK2-Selective InhibitorsThe Journal of Immunology, 2013
- A randomized phase 2a efficacy and safety trial of the topical J anus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasisBritish Journal of Dermatology, 2013
- Clinical Differences between Men and Women with Psoriatic Arthritis: Relevance of the Analysis of Genes and Polymorphisms in the Major Histocompatibility Complex Region and of the Age at Onset of PsoriasisJournal of Immunology Research, 2013
- Association of common variants in JAK2 gene with reduced risk of metabolic syndrome and related disordersBMC Medical Genetics, 2011
- Involvement of Tyrosine Kinase-2 in Both the IL-12/Th1 and IL-23/Th17 Axes In VivoThe Journal of Immunology, 2011
- Janus kinases in immune cell signalingImmunological Reviews, 2009
- Association of Common JAK2 Variants With Body Fat, Insulin Sensitivity and Lipid ProfileObesity, 2008
- Essential Role for Signal Transducer and Activator of Transcription-1 in Pancreatic β-Cell Death and Autoimmune Type 1 Diabetes of Nonobese Diabetic MiceDiabetes, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Lack of association of IL-12 p40 gene polymorphism with peptic ulcer diseaseHuman Immunology, 2005